Table 3.

Key differentially expressed metabolites in ZD309 and its parental lines in heat treatments.

Treatment	ID	Description	VIP	Fold Change	t-Test p-Value	Up/Down
D3HS	M248T257	Meperidine	3.8	20.07	1.69 × 10−13	up
	M178T176	5-Acetyl-2,3-dihydro-6,7-dimethyl-1H-pyrrolizine	2.32	5.62	2.81 × 10−10	up
	M340T240	Acylcarnitine 12:2	2.55	4.97	5.18 × 10−09	up
	M261T257	Khellin	1.73	3.21	8.19 × 10−11	up
	M364T214	Isopentenyladenine-9-N-glucoside	1.08	2.69	3.53 × 10−12	up
	M376T196	Gatifloxacin	1.46	2.69	5.80 × 10−9	up
	M220T114	trans-Zeatin	1.13	2.32	0.0003	up
	M273T337	.beta.-Estradiol	1.3	2.25	0.0003	up
	M175T250	1-Methyl-4-(1-methyl-2-propenyl)-benzene	1.12	2.21	0.0007	up
	M355T293	Isoxanthohumol	1.06	2.11	0.0005	up
D6HS	M211T234	Jasmonic acid	2.74	21.7	1.54 × 10−12	up
	M193T234	2-Methyl-1-phenyl-2-propanyl acetate	2.81	19.64	1.76 × 10−10	up
	M175T234	Glycyl-Valine	2.47	8.62	5.19 × 10−6	up
	M112T61	Cytosine	2.47	10.6	2.06 × 10−6	up
	M364T214	Isopentenyladenine-9-N-glucoside	2.31	10.3	6.59 × 10−16	up
	M150T189	Methionine	2.28	5.44	3.24 × 10−6	up
	M213T374	Dihydrojasmonic acid	1.87	4.83	5.14 × 10−11	up
	M355T309	Isoxanthohumol	1.68	4.22	1.81 × 10−10	up
	M147T195	Coumarin	1.63	3.09	8.10 × 10−5	up
	M261T56_2	Mannose 6-phosphate	1.29	2.08	2.13 × 10−6	up